Elvia Cowan Vaxcyte, Inc. (PCVX) insider trading activity

Elvia Cowan is SVP, FINANCE of Vaxcyte, Inc.. Currently has a direct ownership of 26,156 shares of PCVX, which is worth approximately $1.26 Million. The most recent transaction as insider was on Sep 08, 2025, when has been sold 482 shares (Common Stock) at a price of $32.41 per share, resulting in proceeds of $15,621. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 26.2K

8.5% 3M change

125.91% 12M change

Total Value Held $1.26 Million

Elvia Cowan Transaction History

Date	Transaction	Value	Shares Traded	Shares Held
Sep 08 2025	SELL Payment of exercise price or tax liability	$15,621 $32.41 p/Share	482 Reduced 1.81%	26,156 Common Stock
Sep 07 2025	BUY Grant, award, or other acquisition	-	2,810 Added 9.36%	27,205 Common Stock
Sep 02 2025	SELL Payment of exercise price or tax liability	$17,894 $31.56 p/Share	567 Reduced 2.08%	26,638 Common Stock
Mar 03 2025	SELL Payment of exercise price or tax liability	$23,432 $72.1 p/Share	325 Reduced 1.33%	24,106 Common Stock
Feb 28 2025	SELL Payment of exercise price or tax liability	$17,670 $73.02 p/Share	242 Reduced 0.98%	24,431 Common Stock
Feb 27 2025	BUY Grant, award, or other acquisition	-	5,379 Added 17.9%	24,673 Common Stock
Dec 16 2024	BUY Exercise of conversion of derivative security	$199,998 $25.92 p/Share	7,716 Added 28.57%	19,294 Common Stock
Sep 03 2024	SELL Payment of exercise price or tax liability	$126,121 $110.15 p/Share	1,145 Reduced 9.0%	11,578 Common Stock
Sep 03 2024	SELL Open market or private sale	$538,350 $107.67 p/Share	5,000 Reduced 28.21%	12,723 Common Stock
Sep 03 2024	BUY Exercise of conversion of derivative security	$129,600 $25.92 p/Share	5,000 Added 22.0%	17,723 Common Stock
Jul 16 2024	SELL Open market or private sale	$425,000 $85.0 p/Share	5,000 Reduced 28.21%	12,723 Common Stock
Jul 16 2024	BUY Exercise of conversion of derivative security	$129,600 $25.92 p/Share	5,000 Added 22.0%	17,723 Common Stock
Jul 08 2024	SELL Open market or private sale	$400,000 $80.0 p/Share	5,000 Reduced 28.21%	12,723 Common Stock
Jul 08 2024	BUY Exercise of conversion of derivative security	$129,600 $25.92 p/Share	5,000 Added 22.0%	17,723 Common Stock
Mar 02 2024	SELL Payment of exercise price or tax liability	$23,182 $71.55 p/Share	324 Reduced 2.6%	12,156 Common Stock
Mar 01 2024	SELL Open market or private sale	$862,887 $73.89 p/Share	11,678 Reduced 48.34%	12,480 Common Stock
Mar 01 2024	BUY Exercise of conversion of derivative security	$285,120 $25.92 p/Share	11,000 Added 31.29%	24,158 Common Stock
Feb 29 2024	BUY Grant, award, or other acquisition	-	5,400 Added 29.1%	13,158 Common Stock
Sep 05 2023	SELL Payment of exercise price or tax liability	$31,977 $51.0 p/Share	627 Reduced 7.91%	7,301 Common Stock
Mar 01 2023	BUY Grant, award, or other acquisition	-	7,250 Added 50.0%	7,250 Common Stock

Elvia Cowan

SVP, FINANCE

San Carlos, CA

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells PCVX shares.

Notify only if

Value

Insider Trading

Get notified when an Vaxcyte, Inc. insider buys or sells PCVX shares.

Notify only if

Operation

Value

Type

News

Receive news related to Vaxcyte, Inc.

Track Activities on PCVX

Account